Pfizer fires “rogue” exec
Executive Summary
Pfizer terminates VP-Marketing Peter Rost Dec. 1. Rost made headlines in 2004 when he publicly voiced support for pharmaceutical importation (1"The Pink Sheet" Sept. 27, 2004, p. 15). His termination follows the unsealing of a qui tam lawsuit in which Rost alleged Pharmacia violated the False Claims Act by promoting the human growth hormone product Genotropin off-label prior to Pfizer's acquisition of the firm in 2003. The Boston U.S. Attorney chose not to intervene on Rost's behalf in the case although governmental investigations into other aspects of Pharmacia's Genotropin promotion are ongoing, the company says...
You may also be interested in...
Pfizer’s rogue exec strikes back
Peter Rost files a wrongful termination suit against Pfizer, CEO Hank McKinnell and other senior executives Dec. 12. Rost's suit alleges the defendants violated the N.J. Conscientious Employee Protection Act, which prohibits companies from retaliating against whistleblowers. Pfizer terminated Rost, who held the title VP-marketing, Dec. 1 following the unsealing of a qui tam lawsuit in which Rost alleges Pharmacia promoted the human growth hormone product Genotropin off-label prior to Pifzer's acquisition of the company in 2003 (1"The Pink Sheet" Dec. 5, 2005, In Brief). The Boston U.S. Attorney chose not to intervene in the lawsuit. Rost has been an outspoken advocate of pharmaceutical importation...
Reimportation Advocates Have Support Of “Rogue” Pfizer Exec
The pharmaceutical industry's experience with parallel trade in Europe demonstrates that safety concerns should not prevent Rx importation in the U.S., according to a Pfizer exec
California Court’s Inaction On TiO2 Prop 65 First Amendment Case Breeds New Lawsuits
The Personal Care Products Council seeks to stem the rising tide of titanium dioxide Proposition 65 lawsuits, requesting that a California court prohibit the state’s Attorney General and private enforcers from filing and/or prosecuting new suits against cosmetics companies failing to warn about potential TiO2 exposure.